HANSHI UNION (TIANJIN) STEM CELL RESEARCH INSTITUTE CO LTD

China

Overview

HANSHI UNION (TIANJIN) STEM CELL RESEARCH INSTITUTE CO LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering HUMAN MESENCHYMAL STEM CELL-DERIVED EXOSOMES.

API / Drug Master Files

HANSHI UNION (TIANJIN) STEM CELL RESEARCH INSTITUTE CO LTD holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • HUMAN MESENCHYMAL STEM CELL-DERIVED EXOSOMESActive2024-12-11

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to HANSHI UNION (TIANJIN) STEM CELL RESEARCH INSTITUTE CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

11 Battalion Medical Technology Co., Ltd
China
3D Medicines Inc.
China
3r Environmental Technology Co., Ltd
China
4u Health Co., Ltd
China
5 Plus (ningbo) Healthcare And Technology Co., Ltd.
China
A & D Electronics (shenzhen) Co., Ltd.
China
A-gen Biotech
China
A-one Medical Supplies
China

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo